0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Tourette Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-32K7809
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Tourette Syndrome Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Tourette Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32K7809
Report
December 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tourette Syndrome Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tourette Syndrome Treatment - Market

Tourette Syndrome Treatment - Market

The global market for Tourette Syndrome Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tourette Syndrome Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tourette Syndrome Treatment by region & country, by Type, and by Application.
The Tourette Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tourette Syndrome Treatment.
Market Segmentation

Scope of Tourette Syndrome Treatment - Market Report

Report Metric Details
Report Name Tourette Syndrome Treatment - Market
CAGR 5%
Segment by Type:
  • Antipsychotics
  • Non Antipsychotics
Segment by Application
  • Children
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Mylan NV, Otsuka Holdings Co. Ltd., Sanofi S.A., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Neurocrine Biosciences, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Tourette Syndrome Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Tourette Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Tourette Syndrome Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Tourette Syndrome Treatment - Market report?

Ans: The main players in the Tourette Syndrome Treatment - Market are AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Mylan NV, Otsuka Holdings Co. Ltd., Sanofi S.A., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Neurocrine Biosciences, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Tourette Syndrome Treatment - Market report?

Ans: The Applications covered in the Tourette Syndrome Treatment - Market report are Children, Adult

What are the Type segmentation covered in the Tourette Syndrome Treatment - Market report?

Ans: The Types covered in the Tourette Syndrome Treatment - Market report are Antipsychotics, Non Antipsychotics

1 Market Overview
1.1 Tourette Syndrome Treatment Product Introduction
1.2 Global Tourette Syndrome Treatment Market Size Forecast
1.3 Tourette Syndrome Treatment Market Trends & Drivers
1.3.1 Tourette Syndrome Treatment Industry Trends
1.3.2 Tourette Syndrome Treatment Market Drivers & Opportunity
1.3.3 Tourette Syndrome Treatment Market Challenges
1.3.4 Tourette Syndrome Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tourette Syndrome Treatment Players Revenue Ranking (2023)
2.2 Global Tourette Syndrome Treatment Revenue by Company (2019-2024)
2.3 Key Companies Tourette Syndrome Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tourette Syndrome Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Tourette Syndrome Treatment
2.6 Tourette Syndrome Treatment Market Competitive Analysis
2.6.1 Tourette Syndrome Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tourette Syndrome Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antipsychotics
3.1.2 Non Antipsychotics
3.2 Global Tourette Syndrome Treatment Sales Value by Type
3.2.1 Global Tourette Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tourette Syndrome Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Tourette Syndrome Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Tourette Syndrome Treatment Sales Value by Application
4.2.1 Global Tourette Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tourette Syndrome Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Tourette Syndrome Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tourette Syndrome Treatment Sales Value by Region
5.1.1 Global Tourette Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tourette Syndrome Treatment Sales Value by Region (2019-2024)
5.1.3 Global Tourette Syndrome Treatment Sales Value by Region (2025-2030)
5.1.4 Global Tourette Syndrome Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tourette Syndrome Treatment Sales Value, 2019-2030
5.2.2 North America Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tourette Syndrome Treatment Sales Value, 2019-2030
5.3.2 Europe Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tourette Syndrome Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tourette Syndrome Treatment Sales Value, 2019-2030
5.5.2 South America Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tourette Syndrome Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tourette Syndrome Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tourette Syndrome Treatment Sales Value
6.3 United States
6.3.1 United States Tourette Syndrome Treatment Sales Value, 2019-2030
6.3.2 United States Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tourette Syndrome Treatment Sales Value, 2019-2030
6.4.2 Europe Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tourette Syndrome Treatment Sales Value, 2019-2030
6.5.2 China Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tourette Syndrome Treatment Sales Value, 2019-2030
6.6.2 Japan Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tourette Syndrome Treatment Sales Value, 2019-2030
6.7.2 South Korea Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tourette Syndrome Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tourette Syndrome Treatment Sales Value, 2019-2030
6.9.2 India Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tourette Syndrome Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Profile
7.1.2 AstraZeneca Main Business
7.1.3 AstraZeneca Tourette Syndrome Treatment Products, Services and Solutions
7.1.4 AstraZeneca Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 AstraZeneca Recent Developments
7.2 Boehringer Ingelheim International GmbH
7.2.1 Boehringer Ingelheim International GmbH Profile
7.2.2 Boehringer Ingelheim International GmbH Main Business
7.2.3 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Products, Services and Solutions
7.2.4 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Ingelheim International GmbH Recent Developments
7.3 Eli Lilly and Co.
7.3.1 Eli Lilly and Co. Profile
7.3.2 Eli Lilly and Co. Main Business
7.3.3 Eli Lilly and Co. Tourette Syndrome Treatment Products, Services and Solutions
7.3.4 Eli Lilly and Co. Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Mylan NV Recent Developments
7.4 Mylan NV
7.4.1 Mylan NV Profile
7.4.2 Mylan NV Main Business
7.4.3 Mylan NV Tourette Syndrome Treatment Products, Services and Solutions
7.4.4 Mylan NV Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Mylan NV Recent Developments
7.5 Otsuka Holdings Co. Ltd.
7.5.1 Otsuka Holdings Co. Ltd. Profile
7.5.2 Otsuka Holdings Co. Ltd. Main Business
7.5.3 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Products, Services and Solutions
7.5.4 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Otsuka Holdings Co. Ltd. Recent Developments
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Profile
7.6.2 Sanofi S.A. Main Business
7.6.3 Sanofi S.A. Tourette Syndrome Treatment Products, Services and Solutions
7.6.4 Sanofi S.A. Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Sanofi S.A. Recent Developments
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Profile
7.7.2 Pfizer Inc. Main Business
7.7.3 Pfizer Inc. Tourette Syndrome Treatment Products, Services and Solutions
7.7.4 Pfizer Inc. Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Pfizer Inc. Recent Developments
7.8 Sun Pharmaceutical Industries Ltd
7.8.1 Sun Pharmaceutical Industries Ltd Profile
7.8.2 Sun Pharmaceutical Industries Ltd Main Business
7.8.3 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Products, Services and Solutions
7.8.4 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
7.9 Neurocrine Biosciences, Inc.
7.9.1 Neurocrine Biosciences, Inc. Profile
7.9.2 Neurocrine Biosciences, Inc. Main Business
7.9.3 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Products, Services and Solutions
7.9.4 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Neurocrine Biosciences, Inc. Recent Developments
7.10 Novartis AG
7.10.1 Novartis AG Profile
7.10.2 Novartis AG Main Business
7.10.3 Novartis AG Tourette Syndrome Treatment Products, Services and Solutions
7.10.4 Novartis AG Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Novartis AG Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Profile
7.11.2 Teva Pharmaceutical Industries Ltd. Main Business
7.11.3 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Products, Services and Solutions
7.11.4 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Tourette Syndrome Treatment Industrial Chain
8.2 Tourette Syndrome Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tourette Syndrome Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Tourette Syndrome Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Tourette Syndrome Treatment Market Trends
    Table 2. Tourette Syndrome Treatment Market Drivers & Opportunity
    Table 3. Tourette Syndrome Treatment Market Challenges
    Table 4. Tourette Syndrome Treatment Market Restraints
    Table 5. Global Tourette Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tourette Syndrome Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Tourette Syndrome Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Tourette Syndrome Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Tourette Syndrome Treatment
    Table 10. Global Tourette Syndrome Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Tourette Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Tourette Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Tourette Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Tourette Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Tourette Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Tourette Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Tourette Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Tourette Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Tourette Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Tourette Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Tourette Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Tourette Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Tourette Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Tourette Syndrome Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Tourette Syndrome Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Tourette Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Tourette Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Tourette Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. AstraZeneca Basic Information List
    Table 32. AstraZeneca Description and Business Overview
    Table 33. AstraZeneca Tourette Syndrome Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Tourette Syndrome Treatment Business of AstraZeneca (2019-2024)
    Table 35. AstraZeneca Recent Developments
    Table 36. Boehringer Ingelheim International GmbH Basic Information List
    Table 37. Boehringer Ingelheim International GmbH Description and Business Overview
    Table 38. Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Boehringer Ingelheim International GmbH (2019-2024)
    Table 40. Boehringer Ingelheim International GmbH Recent Developments
    Table 41. Eli Lilly and Co. Basic Information List
    Table 42. Eli Lilly and Co. Description and Business Overview
    Table 43. Eli Lilly and Co. Tourette Syndrome Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Eli Lilly and Co. (2019-2024)
    Table 45. Eli Lilly and Co. Recent Developments
    Table 46. Mylan NV Basic Information List
    Table 47. Mylan NV Description and Business Overview
    Table 48. Mylan NV Tourette Syndrome Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Mylan NV (2019-2024)
    Table 50. Mylan NV Recent Developments
    Table 51. Otsuka Holdings Co. Ltd. Basic Information List
    Table 52. Otsuka Holdings Co. Ltd. Description and Business Overview
    Table 53. Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Otsuka Holdings Co. Ltd. (2019-2024)
    Table 55. Otsuka Holdings Co. Ltd. Recent Developments
    Table 56. Sanofi S.A. Basic Information List
    Table 57. Sanofi S.A. Description and Business Overview
    Table 58. Sanofi S.A. Tourette Syndrome Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Sanofi S.A. (2019-2024)
    Table 60. Sanofi S.A. Recent Developments
    Table 61. Pfizer Inc. Basic Information List
    Table 62. Pfizer Inc. Description and Business Overview
    Table 63. Pfizer Inc. Tourette Syndrome Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Pfizer Inc. (2019-2024)
    Table 65. Pfizer Inc. Recent Developments
    Table 66. Sun Pharmaceutical Industries Ltd Basic Information List
    Table 67. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 68. Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Sun Pharmaceutical Industries Ltd (2019-2024)
    Table 70. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 71. Neurocrine Biosciences, Inc. Basic Information List
    Table 72. Neurocrine Biosciences, Inc. Description and Business Overview
    Table 73. Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Neurocrine Biosciences, Inc. (2019-2024)
    Table 75. Neurocrine Biosciences, Inc. Recent Developments
    Table 76. Novartis AG Basic Information List
    Table 77. Novartis AG Description and Business Overview
    Table 78. Novartis AG Tourette Syndrome Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Novartis AG (2019-2024)
    Table 80. Novartis AG Recent Developments
    Table 81. Teva Pharmaceutical Industries Ltd. Basic Information List
    Table 82. Teva Pharmaceutical Industries Ltd. Description and Business Overview
    Table 83. Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Tourette Syndrome Treatment Business of Teva Pharmaceutical Industries Ltd. (2019-2024)
    Table 85. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Tourette Syndrome Treatment Downstream Customers
    Table 89. Tourette Syndrome Treatment Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Tourette Syndrome Treatment Product Picture
    Figure 2. Global Tourette Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tourette Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Tourette Syndrome Treatment Report Years Considered
    Figure 5. Global Tourette Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tourette Syndrome Treatment Revenue in 2023
    Figure 7. Tourette Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Antipsychotics Picture
    Figure 9. Non Antipsychotics Picture
    Figure 10. Global Tourette Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Tourette Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Children
    Figure 13. Product Picture of Adult
    Figure 14. Global Tourette Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Tourette Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Tourette Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Tourette Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Tourette Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Tourette Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Tourette Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Tourette Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Tourette Syndrome Treatment Sales Value (%), (2019-2030)
    Figure 27. United States Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Tourette Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Tourette Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Tourette Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. Tourette Syndrome Treatment Industrial Chain
    Figure 49. Tourette Syndrome Treatment Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Autism Intervention Software Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37O18689
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Implantable Neurostimulation System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-1Y15335
Tue Dec 10 00:00:00 UTC 2024

Add to Cart

D-Amphetamine Sulfate API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0I12614
Fri Dec 06 00:00:00 UTC 2024

Add to Cart

Relapsing-Remitting Multiple Sclerosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19Z9868
Wed Dec 04 00:00:00 UTC 2024

Add to Cart